Table 1.
Action | Administration | Advantages | Disadvantages and limitations | |
Clinical study | ||||
Corticosteroids | Steroidal | Oral intake | Strongly inhibits the infiltration of inflammatory cells, the hyperplasia associated with granulation, and the fibrosis of the remaining submucosal layer | General side effects (severe infection, peptic ulcer, hyperglycemia, psychiatric symptoms, and osteoporosis) |
Delayed wound healing | ||||
Triamcinolone acetonide | Steroidal | Local injection | Inhibits the infiltration of inflammatory cells, the hyperplasia associated with granulation, and the fibrosis of the remaining submucosal layer | Risk of ulcer formation due to accidental injection into the muscularis |
Delayed wound healing | ||||
Pre-clinical study | ||||
MMC | Inhibition of DNA synthesis | Local injection | Inhibits the proliferation and activation of fibroblasts | An effect has not been shown for the prevention of esophageal strictures, although MMC improves recurrent dysphagia or restenosis after the dilatation of esophageal strictures |
The risks of perforation and secondary malignancy | ||||
N-acetylcysteine | Antioxidant molecule | Oral intake | Antifibrotic effect without the inhibition of wound healing | Insufficient effect in an animal model of severe esophageal stricture |
MMC: Mitomycin C.